DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
299	嚢胞性線維症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00411736 (ClinicalTrials.gov)	May 2008	14/12/2006	Scandinavian Cystic Fibrosis Azithromycin Study	Supplementary Oral Azithromycin in Treatment of Intermittent Pseudomonas Aeruginosa Colonization in CF-patients With Inhaled Colistin and Oral Ciprofloxacin; Postponing Next Isolate of Pseudomonas and Prevention of Chronic Infection. A Prospective, Double-blinded, Placebo-controlled Scandinavian Multi-centre Study.	Cystic Fibrosis	Drug: Study medication, azithromycin or placebo;Drug: Azithromycin or placebo tablets	Rigshospitalet, Denmark	Cystic Fibrosis Foundation Therapeutics	Completed	1 Year	N/A	Both	45	Phase 4	Denmark;Norway;Sweden

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

NCT00411736
(ClinicalTrials.gov)

May 2008

14/12/2006

Scandinavian Cystic Fibrosis Azithromycin Study

Supplementary Oral Azithromycin in Treatment of Intermittent Pseudomonas Aeruginosa Colonization in CF-patients With Inhaled Colistin and Oral Ciprofloxacin; Postponing Next Isolate of Pseudomonas and Prevention of Chronic Infection. A Prospective, Double-blinded, Placebo-controlled Scandinavian Multi-centre Study.

Cystic Fibrosis

Drug: Study medication, azithromycin or placebo;Drug: Azithromycin or placebo tablets

Rigshospitalet, Denmark

Cystic Fibrosis Foundation Therapeutics

Completed

1 Year

N/A

Both

Phase 4

Denmark;Norway;Sweden